TABLE 7.
Cumulative 30-day and 1-year outcomes.
| Overall (N = 155) | Severe PPM (N = 10) | Moderate PPM (N = 22) | None (N = 123) | P-value | |
| 30-day | |||||
| CV death | 7 (4.5%) | 0 (0) | 4 (18%) | 3 (2.4%) | 0.003 |
| All-cause death | 11 (7.1%) | 1 (10%) | 4 (18%) | 6 (3.8%) | 0.08 |
| Valve related hospitalization | 5 (3%) | 2 (20%) | 0 (0) | 3 (2.4%) | 0.001 |
| Valve thrombosis | 2 (1.3%) | 0 (0) | 2 (9%) | 0 (0) | 0.001 |
| NYHA class III-IV | 12 (7.7%) | 3 (30%) | 0 (0) | 9 (7.4%) | 0.0001 |
| 1-year | |||||
| All-cause death | 20 (12.9%) | 4 (40%) | 4 (18%) | 12 (9.7%) | 0.016 |
| CV death | 9 (5.8%) | 2 (20%) | 4 (18%) | 3 (2.4%) | 0.002 |
| Valve related hospitalization | 10 (6.5%) | 2 (20%) | 2 (9%) | 6 (5%) | 0.15 |
| Valve thrombosis | 2 (1.3%) | 0 (0) | 2 (9%) | 0 (0) | 0.002 |
| NYHA class III-IV | 9 (5.8%) | 2 (20%) | 0 (0) | 7 (5.7%) | 0.0001 |
CV, cardiovascular.